|
1
|
Asghar U, Barr A, Cuts R, Beaney M, Babina I, Sampath D, Lacap J, Crocker L, Young A, Nerukar A, Pearson A, Herrera-Abreu M, Bakal C, Turner N. Abstract P5-04-01: Cell cycle dynamics at single cell level dictates response to CDK4/6 inhibition. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-04-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Collapse
Affiliation(s)
- U Asghar
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - A Barr
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - R Cuts
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - M Beaney
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - I Babina
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - D Sampath
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - J Lacap
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - L Crocker
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - A Young
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - A Nerukar
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - A Pearson
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - M Herrera-Abreu
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - C Bakal
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| | - N Turner
- The Institute of Cancer Research (ICR), London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Genentech (Roche), San Francisco
| |
Collapse
|